The landmark text in medical pharmacology is now in full colorIncludes DVD with image bankA Doody's Core Title for 2017!4 STAR DOODY'S REVIEW!"This 12th edition of the most authoritative book in pharmacology is the best both in content and physical appearance....This edition of Goodman & Gilman's continues to be the most authoritative and widely used resource bridging the discipline of pharmacology with therapeutics. Moreover, readers will find this edition to be substantially improved from past editions in both content and physical appearance."--Doody's Review ServiceThe most universally respected and read medical text in all of pharmacology, Goodman & Gilman's The Pharmacological Basis of Therapeutics represents the pinnacle of authority and accuracy in describing the actions and uses of therapeutic agents in relation to physiology and pathophysiology. Goodman & Gilman's careful balance of basic science and clinical application has guided thousands of practitioners and students to a clear understanding of the drugs essential to preventing, diagnosing, and treating disease.Enriched by a new full-color presentation and updated to reflect all critical new developments in drug action and drug-disease interaction, the twelfth edition includes more than 440 color illustrations depicting key principles and actions of specific pathways and therapeutic agents. The companion DVD includes all the images and tables in the text along with narrated animations.Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12e is divided into nine sections, covering:General PrinciplesNeuropharmacologyModulation of Cardiovascular FunctionInflammation, Immunomodulation, and HematopoiesisEndocrine PharmacologyGastrointestinal PharmacologyChemotherapy of Infectious DiseaseChemotherapy of Neoplastic DiseasesSpecial Systems PharmacologyMore than a textbook, Goodman & Gilman's is a working template for the effective and rational prescribing of drugs in daily practice.
Les mer
The "Harrison's of Pharmacology" -- now in full color
Contributors
Consultants to the Editors
Preface
Preface to the First Edition
SECTION I: GENERAL PRINCIPLES
1. Drug Invention and the Pharmaceutical Industry, Suzanne M. Rivera and Alfred Goodman Gilman
2. Pharmacokinetics: The Dynamics of Drug Absorption, Distribution, Metabolism, and Elimination, Iain L. O. Buxton and Leslie Z. Benet
3. Pharmacodynamics: Molecular Mechanisms of Drug Action, Donald K. Blumenthal and James C. Garrison
4. Drug Toxicity and Poisoning, Kevin C. Osterhoudt and Trevor M. Penning
5. Membrane Transporters and Drug Response, Kathleen M. Giacomini and Yuichi Sugiyama
6. Drug Metabolism, Frank J. Gonzalez, Michael Coughtrie, and Robert H. Tukey
7. Pharmacogenetics, Mary V. Relling and Kathleen M. Giacomini
SECTION II: NEUROPHARMACOLOGY
8. Neurotransmission: The Autonomic and Somatic Motor Nervous Systems, Thomas C. Westfall and David P. Westfall
9. Muscarinic Receptor Agonists, Joan Heller Brown and Nora Laiken
10. Anticholinesterase Agents, Palmer Taylor
11. Agents Acting at the Neuromuscular Junction and Autonomic Ganglia, Ryan E. Hibbs and Alexander C. Zambon
12. Adrenergic Agonists and Antagonists, Thomas C. Westfall and David P. Westfall
13. 5-Hydroxytryptamine (Serotonin) and Dopamine, Elaine Sanders-Bush and Lisa Hazelwood
14. Neurotransmission and the Central Nervous System, Perry B. Molinoff
15. Drug Therapy of Depression and Anxiety Disorders, James M. O'Donnell and Richard C. Shelton
16. Pharmacotherapy of Psychosis and Mania, Jonathan M. Meyer
17. Hypnotics and Sedatives, S. John Mihic and r. Adron Harris
18. Opioids, Analgesia, and Pain Management, Tony L. Yaksh and Mark S. Wallace
19. General Anesthetics and Therapeutic Gases, Piyush M. Patel, Hemal H. Patel, and David M. Roth
20. Local Anesthetics, William A. Catteral nad Kenneteh Mackie
21. Pharmacotherapy of the Epilepsies, James O. McNamara
22. Treatment of Central Nervous System Degenerative Disorders, David G. Standaert and Erik D. Roberson
23. Ethanol and Methanol, Marc A. Schuckit
24. Drug Addition, Charles P. O'Brien
SECTION III: MODULATION OF CARDIOVASCULAR FUNCTION
25. Regulation of Renal Function and Vascular Volume, Robert F. Reilly and Edwin K. Jackson
26. Renin and Angiotensin, Randa Hilal-Dandan
27. Treatment of Myocardial Ischemia and Hypertension, Thomas Michel and Brian B. Hoffman
28. Pharmacotherapy of Congestive Heart Failure, Bradley A. Maron and Thomas P. Rocco
29. Anti-Arrhythmic Drugs, Kevin J. Sampson and Robert S. Kass
30. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs, Jeffrey I. Weitz
31. Drug Therapy for Hypercholesterolemia and Dyslipiedmia, Thomas P. Bersot
SECTION IV: INFLAMMATION, IMMUNOMODULATION, AND HEMATOPOIESIS
32. Histamine, Bradykinin, and Their Antagonists, Randal A. Skidgel, Allen P. Kaplan, and Ervin G. Erdoes
33. Lipid-Derived Autacoids: Eicosanoids and Platelet-Activating Factor, Emer M. Smyth, Tilo Grosser, and Garret A. Fitzgerald
34. Anti-inflammatory, Antipyretic, and Analgesic Agents; Pharmacology of Gout, Tilo Grosser, Emer Smyth, and Garret A. FitzGerald
35. Immunosupressants, Tolerogens, and Immunostimulants, Alan M. Krensky, William M. Bennett, and Flavio Vincenti
36. Pulmonary Pharmacology, Peter J. Barnes
37. Hematopoietic Agents: Growth Factors, Minerals, and Vitamins, Kenneth Kaushansky and Thomas J. Kipps
SECTION V: HORMONES AND HORMONE ANTAGONISTS
38. Introduction to Endocrinology: The Hypothalamic-Pituitary Axis, Keith L. Parker and Bernard P. Schimmer
39. Thyroid and Anti-Thyroid Drugs, Gregory A. Brent and Ronald J. Koenig
40. Estrogens and Progestins, Ellis R. Levin and Stephen R. Hammes
41. Androgens, Peter J. Snyder
42. ACTH, Adrenal Steroids, and Pharmacology of the Adrenal Cortex, Bernard P. Schimmer and John W. Funder
43. Endocrine Pancreas and Pharmacotherapy of Diabetes Mellitus and Hypoglycemia, Alvin C. Powers and David D'Alessio
44. Agents Affecting Mineral Ion Homeostatis and Bone Turnover, Peter A. Friedman
SECTION VI: DRUGS AFFECTING GASTROINTESTINAL FUNCTION
45. Pharmacotherapy of Gastric Acidity, Peptic Ulcers, and Gastroesophageal Reflux Disease, John L. Wallace and Keith A. Sharkey
46. Treatment of Disorders of Bowel Motility and Water Flux: Anti-Emetics; Agents Used in Biliary and Pancreative Disease, Keith A. Sharkey and John L. Wallace
47. Pharmacotherapy of Inflammatory Bowel Disease, John L. Wallace and Keith A. Sharkey
SECTION VII: CHEMOTHERAPY OF MICROBIAL DISEASES
48. General Principles of Antimicrobial Therapy, Tawanda Gumbo
49. Chemotherapy of Malaria, Joseph M. Vinetz, Jerome Clain, Viengngeun Bounkeua, Richard T. Eastman, and David Fidock
50. Chemotherapy of Protozoal Infections: Amebiasis, Giardiasis, Trichomoniasis, Trypanosomiasis, Leishmaniasis, and Other Protozoal Infections, Margaret A. Phillips, Samuel L. Stanley, Jr.
51. Chemotherapy of Helminth Infections, James McCarthy, Alex Loukas, and Peter J. Hotez
52. Sulfonamides, Trimethoprim-Sulfamethoxazole, Quinolones, and Agents for Urinary Tract Infections, William A. Petri, Jr.
53. Penicillins, Cephalosporins, and Other ss-Lactam Antibiotics, William A. Petri, Jr.
54. Aminoglycosides, Conan MacDougall and Henry F. Chambers
55. Protein Synthesis Inhibitors and Miscellaneous Antibacterial Agents, Conan MacDougall and Henry F. Chambers
56. Chemotherapy of Tuberculosis, Mycobacterium Avium Complex Disease, and Leprosy, Tawanda Gumbo
57. Antifungal Agents, John E. Bennett
58. Antiviral Agents (Nonretroviral), Edward P. Acosta and Charles Flexner
59. Antiretroviral Agents and Treatment of HIV Infection, Charles Flexner
SECTION VIII: CHEMOTHERAPY OF NEOPLASTIC DISEASES
60. General Principles of Cancer Chemotherapy, Bruce A. Chabner
61. Cytotoxic Agents, Bruce A. Chabner, Joseph Bertino, James Cleary, Taylor Ortiz, Andrew Lane, Jeffrey G. Supko, and David Ryan
62. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines, Bruce A. Chabner, Jeffrey Barnes, Joel Neal, Erin Olson, Hamza Mujagic, Lecia Sequist, Wynham Wilson, Dan L. Longo, Constantine Mitsiades, and Paul Richardson
63. Natural Products in Cancer Chemotherapy: Hormones and Related Agents, Beverly Moy, Paul Goss, Richard J. Lee, and Matthew Smith
SECTION IX: OPHTHALMOLOGY
64. Ocular Pharmacology, Jeffrey D. Henderer and Christopher J. Rapuano
65. Dermatological Pharmacology, Craig Burkhart, Dean Morrell, and Lowell Goldsmith
66. Contraception and Pharmacotherapy of Obstetrical and Gynecological Disorders, Bernard P. Schimmer and Keith L. Parker
67. Environmental Toxicology: Carcinogens and Heavy Metals, Michael C. Byrns and Trevor M. Penning
APPENDICES
I. Principles of Prescription Order Writing and Patient Compliance, Iain L.O. Buxton
II. Design and Optimization of Dosage Regimens: Pharmacokinetic Data, Kenneth E. Thummel, Danny D. Shen, and Nina Isoherranen
Index
Les mer
Produktdetaljer
ISBN
9780071624428
Publisert
2011-02-16
Utgave
12. utgave
Utgiver
Vendor
McGraw-Hill Medical
Vekt
3789 gr
Høyde
262 mm
Bredde
211 mm
Dybde
70 mm
Aldersnivå
06, P
Språk
Product language
Engelsk
Format
Product format
Annet
Antall sider
1808
Biographical note
Editor:
Laurence L. Brunton, PhD
Professor of Pharmacology and Medicine
University of California San Diego
School of Medicine
La Jolla, CA
Associate Editors:
Bruce A. Chabner, MD
Clinical Director
MDF Cancer Center
Professor of Medicine
Harvard Medical School
Boston, MA
Bjorn Christian Knollmann, MD, PhD
Associate Professor of Medicine and Pharmacology
Oates Institute for Experimental Therapeutics
Vanderbilt University School of Medicine
Division of Clinical Pharmacology
Nashville, TN